Jeff Yass’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-11,775
Closed -$223K 10659
2016
Q4
$223K Buy
+11,775
New +$226K ﹤0.01% 8500
2015
Q2
Sell
-13,074
Closed -$286K 10688
2015
Q1
$286K Buy
+13,074
New +$282K ﹤0.01% 8056

Other funds holding ENTL

Jeff Yass's ENTL Position: Q1 2017 in Review

Jeff Yass sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2017, closing a stake of 11,775 shares — an estimated $223K sold.

Jeff Yass first reported a position in ENTL in Q1 2015 and held it in 2 quarters. The position peaked at $286K in Q1 2015. 69 funds tracked by Wall St. Rank hold ENTL as of Q1 2017.

  • Jeff Yass reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • Jeff Yass sold 11,775 Entellus Medical, Inc. Common Stock shares in Q1 2017, an estimated $223K.
  • Jeff Yass first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 2 quarters.
  • Jeff Yass's Entellus Medical, Inc. Common Stock position peaked at $286K in Q1 2015.
  • 69 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2017.

Based on Susquehanna International Group's 13F filing for Q1 2017, filed 15 May 2017.